CC BY-NC-ND 4.0 · AJP Rep 2020; 10(04): e408-e412
DOI: 10.1055/s-0040-1721443
Case Report

Implementation of Evidence-Based Cervical Ripening Protocol: Outcomes and Next Steps

1   Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, California
,
1   Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, California
,
Robyn Lamar
1   Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, California
,
Melissa G. Rosenstein
1   Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, California
› Author Affiliations

Abstract

Objective A prominent randomized controlled trial demonstrated that low-dose misoprostol with the concurrent cervical Foley shortened the median time to delivery when compared with either method alone. Our study aims to address implementation of this protocol and evaluate its impact on time to delivery.

Study Design This was a retrospective before-and-after study of nulliparous women who delivered nonanomalous, term, singletons at the University of California San Francisco (UCSF) in two separate 2-year periods before and after changes in UCSF's cervical ripening protocol. The primary outcome was time from first misoprostol dose to delivery.

Results A total of 1,496 women met inclusion criteria, with 698 in the preimplementation group and 798 in the postimplementation group. There were no statistically significant differences in time to delivery (29 vs. 30 hours, p = 0.69), rate of cesarean delivery (30 vs. 26%, p = 0.09), or cesarean delivery for fetal indications (11 vs. 8%, p = 0.15) between the groups.

Conclusion Implementing evidence-based low-dose misoprostol with the concurrent cervical Foley did not change the time to delivery, time to vaginal-delivery, or likelihood of vaginal delivery in our population. This may be due to differences in labor management practices and incomplete fidelity to the protocol. Real-world effectiveness of these interventions will vary and should be considered when choosing an induction method.



Publication History

Received: 15 May 2020

Accepted: 24 September 2020

Article published online:
03 December 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 ACOG Committee on Practice Bulletins – Obstetrics. 107: induction of labor. Obstet Gynecol 2009; 114 (2 Pt 1): 386-397
  • 2 Alfirevic Z, Kelly AJ, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst Rev 2009; (04) CD003246
  • 3 Kehl S, Ehard A, Berlit S, Spaich S, Sütterlin M, Siemer J. Combination of misoprostol and mechanical dilation for induction of labour: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2011; 159 (02) 315-319
  • 4 Hill JB, Thigpen BD, Bofill JA, Magann E, Moore LE, Martin Jr JN. A randomized clinical trial comparing vaginal misoprostol versus cervical Foley plus oral misoprostol for cervical ripening and labor induction. Am J Perinatol 2009; 26 (01) 33-38
  • 5 Jozwiak M, Bloemenkamp KW, Kelly AJ, Mol BWJ, Irion O, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev 2012; (03) CD001233
  • 6 Atad J, Hallak M, Auslender R, Porat-Packer T, Zarfati D, Abramovici H. A randomized comparison of prostaglandin E2, oxytocin, and the double-balloon device in inducing labor. Obstet Gynecol 1996; 87 (02) 223-227
  • 7 Kehl S, Ziegler J, Schleussner E. et al. Sequential use of double-balloon catheter and oral misoprostol versus oral misoprostol alone for induction of labour at term (CRBplus trial): a multicentre, open-label randomised controlled trial. BJOG 2015; 122 (01) 129-136
  • 8 Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and pharmacologic methods of labor induction: a randomized controlled trial. Obstet Gynecol 2016; 128 (06) 1357-1364
  • 9 Ten Eikelder MLG, Oude Rengerink K, Jozwiak M. et al. Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial. Lancet 2016; 387 (10028): 1619-1628
  • 10 Kehl S, Böhm L, Weiss C. et al. Timing of sequential use of double-balloon catheter and oral misoprostol for induction of labor. J Obstet Gynaecol Res 2016; 42 (11) 1495-1501
  • 11 Kehl S, Weiss C, Dammer U. et al. Double-balloon catheter and sequential oral misoprostol versus oral misoprostol alone for induction of labour at term: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 2016; 204: 78-82
  • 12 Colón I, Clawson K, Hunter K, Druzin ML, Taslimi MM. Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. Am J Obstet Gynecol 2005; 192 (03) 747-752
  • 13 Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 2007; 99 (Suppl. 02) S160-S167
  • 14 Kundodyiwa TW, Alfirevic Z, Weeks AD. Low-dose oral misoprostol for induction of labor: a systematic review. Obstet Gynecol 2009; 113 (2 Pt 1): 374-383
  • 15 World Health Organization. WHO Recommendations for Induction of Labour. Accessed October 17, 2020 at: https://apps.who.int/iris/bitstream/handle/10665/44531/9789241501156_eng.pdf;jsessionid=8C559C1CDF51DE26A9A0CF84CB4D7092?sequence=1
  • 16 International Federation of Gynecology and Obstetrics. The global voice for women's health. Accessed April 9, 2020 at: https://www.figo.org/sites/default/files/uploads/project-publications/Miso/FIGO_Dosage_ChartEN_0.pdf
  • 17 National Collaborating Centre for Women's and Children's Health, Commissioned by the National Institute for Health and Clinical Excellence. Induction of labour. Accessed October 17, 2020 at: https://www.nice.org.uk/guidance/cg70
  • 18 Alfirevic Z, Keeney E, Dowswell T. et al. Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ 2015; 350: h217-h217
  • 19 Ten Eikelder MLG, Mast K, van der Velden A, Bloemenkamp KWM, Mol BW. Induction of labor using a foley catheter or misoprostol: a systematic review and meta-analysis. Obstet Gynecol Surv 2016; 71 (10) 620-630
  • 20 Al Kadri HMF, Al Anazi BK, Tamim HM. Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study. Arch Gynecol Obstet 2011; 283 (06) 1207-1213
  • 21 Ornat L, Alonso-Ventura V, Bueno-Notivol J, Chedraui P, Pérez-López FR. Misoprostol combined with cervical single or double balloon catheters versus misoprostol alone for labor induction of singleton pregnancies: a meta-analysis of randomized trials. J Matern Neonatal Med 2019; 33 (20) 3453-3468
  • 22 Husain S, Husain S, Izhar R. Oral misoprostol alone versus oral misoprostol and Foley's catheter for induction of labor: A randomized controlled trial. J Obstet Gynaecol Res 2017; 43 (08) 1270-1277
  • 23 Attanasio LB, Kozhimannil KB, Kjerulff KH. Factors influencing women's perceptions of shared decision making during labor and delivery: Results from a large-scale cohort study of first childbirth. Patient Educ Couns 2018; 101 (06) 1130-1136
  • 24 Klassa PJ, Dendrinos S, Penn A, Radke J. Shared decision making: through the patient's eyes. J Perinat Neonatal Nurs 2016; 30 (03) 228-232